Besides the inter-tumor heterogeneity, five out of seven (71.4%) of these HGSOCs showed significant (not shown) intra-tumor molecular heterogeneity: for example, sample #538 had a VAF of 58.9% for mutation identified in TP53 coexisting with a PTEN mutation (see Table S1). Here, PTEN is linked to neoplasm.